BRIEF-Avidity Biosciences Announces Positive Pre-BLA Meeting With US FDA For del-zota In DMD44

Reuters
Oct 13, 2025
BRIEF-<a href="https://laohu8.com/S/RNA">Avidity Biosciences</a> Announces Positive Pre-BLA Meeting With US FDA For del-zota In DMD44

Oct 13 (Reuters) - Avidity Biosciences Inc RNA.O:

  • AVIDITY BIOSCIENCES ANNOUNCES POSITIVE PRE-BLA MEETING WITH U.S. FDA FOR DEL-ZOTA IN DMD44 WITH A SUBMISSION PLANNED FOR Q1 2026

  • AVIDITY BIOSCIENCES INC - BLA SUBMISSION FOR DEL-ZOTA UPDATED TO Q1 2026

Source text: ID:nPn1wBqfLa

Further company coverage: RNA.O

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10